Company news

Jointown Pharmaceutical Group Co., Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

(600998)"Jointown Pharmaceutical Group Co., Ltd."Indicative Announcement on the 4th Extraordinary General Meeting in 2026

November 2, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Provision of Online Voting Reminder Service for General Meeting

November 2, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Outline of Q3 2026 Performance Briefing

November 2, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Election of Employee Representative Director for the 7th Board of Directors

November 2, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Signing of the Strategic Cooperation Agreement with JOINN LABORATORIES (CHINA) CO., LTD. and Other Parties

October 29, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Shareholding Increase by the Chairman, Vice Chairman and General Manager

October 29, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Obtaining Drug Registration Certificate for Vitamin B6 Injection

October 28, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Voluntary Disclosure of Shareholder Rewards Event

October 26, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Report for Q3 2026

October 23, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Pre-announcement on Convening the Q3 2026 Performance Briefing

October 23, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Notice on Convening the 4th Extraordinary General Meeting in 2026

October 23, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on the 2026 Interim Dividend Distribution Plan

October 23, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 25th Meeting of the 6th Board of Directors

October 23, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Election of New Board of Directors

October 23, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Progress in Providing Guarantees for Subsidiaries

October 21, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Completion of Redemption of the 2nd Tranche of Super Short-term Commercial Paper for 2026 (Supporting the Elderly Care Industry)

October 20, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Completion of Industrial and Commercial Registration Changes and Filing of the Articles of Association

October 20, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Acquisition of Patents in Q3 2026

October 19, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Issuance Results of the 3rd Tranche of Super Short-term Commercial Paper for 2026 (Supporting the Elderly Care Industry)

October 15, 2026

(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Entrusted Wealth Management with Temporarily Idle Funds for Q3 2026

October 13, 2026

Announcement on Release of Pledge and Pledge of Shares by the Controlling Shareholder and Its Person Acting in Concert

September 28, 2026

Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026

September 17, 2026

Announcement on Progress in Providing Guarantees for Subsidiaries

September 11, 2026

Indicative Announcement on Convening the 3rd Extraordinary General Meeting in 2026

September 9, 2026

Announcement on Outline of the 2026 Semi-annual Performance Briefing

September 2, 2026

Announcement on Resolutions of the 24th Meeting of the 6th Board of Directors

August 31, 2026

Announcement on Winning of a Bid by a Controlled Subsidiary for the County-level Medical Community Information Integration Construction Project

August 28, 2026

Announcement on Issuance of the Second Tranche of Asset-backed Commercial Paper for 2026 (Supporting the Elderly Care Industry) and Related Party Transactions

August 27, 2026

Semi-annual Report for 2026

August 24, 2026

Announcement on Signing of the "Strategic Cooperation Agreement" with Guomin Pension & Insurance Co., Ltd. and Related Party Transactions

August 21, 2026

Announcement on Resolutions of the 22nd Meeting of the 6th Board of Directors

August 20, 2026

Announcement on Provision of Online Voting Reminder Service for General Meeting

August 14, 2026

Announcement on Acquisition of the Compliance Management System Certification Certificate

August 4, 2026

Announcement on Election of Directors, Appointment of Senior Management and Resignation of Directors

July 28, 2026

Announcement on Early Release of Pledge and Pledge of Shares by the Controlling Shareholder and Its Persons Acting in Concert

July 24, 2026

Announcement on Completion of Redemption of the First Tranche of Sci-Tech Innovation Bonds in 2026

July 20, 2026

Announcement on Inclusion of Products of Subsidiaries in the "National Essential Medicines List (2026 Edition)"

July 15, 2026

Announcement on Progress in Providing Guarantee for Subsidiary

July 10, 2026

Announcement on Entrusted Wealth Management of Temporarily Idle Funds for Q2 2026

July 6, 2026

Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction

July 1, 2026

Announcement on Resolutions of the 20th Meeting of the 6th Board of Directors

June 26, 2026

Announcement on Release and Pledge of Shares by the Controlling Shareholder and Its Persons Acting in Concert

June 23, 2026

Announcement on Progress in Providing Guarantee for Subsidiary

June 16, 2026

Announcement on Issuance of the Phase I Asset-backed Notes for 2026 and Related Party Transactions

June 10, 2026

Announcement on Subsidiary Obtaining Approval for Marketing of Chemical APIs

June 2, 2026

Announcement on Implementation of Dividend Distribution for 2025

June 1, 2026

Announcement on Subsidiary's Drug Passing Generic Drug Consistency Evaluation

May 26, 2026

Announcement on Resolutions of the 2025 Annual General Meeting

May 21, 2026

Indicative Announcement on Convening the 2025 Annual General Meeting

May 14, 2026

Announcement on Recognition of Subsidiary as High-tech Enterprise

May 12, 2026

Older news releases →